Evaluation of the effect of RNA secondary structure on Cas13d-mediated target RNA cleavage.

CRISPR-Cas13d MT: RNA/DNA Editing RNA interference RNA structure SARS-CoV-2 cleavage activity gene editing targeting efficiency

Journal

Molecular therapy. Nucleic acids
ISSN: 2162-2531
Titre abrégé: Mol Ther Nucleic Acids
Pays: United States
ID NLM: 101581621

Informations de publication

Date de publication:
10 Sep 2024
Historique:
received: 01 09 2023
accepted: 16 07 2024
medline: 2 9 2024
pubmed: 2 9 2024
entrez: 2 9 2024
Statut: epublish

Résumé

The clustered regularly interspaced short palindromic repeats (CRISPR)-Cas13d system was adapted as a powerful tool for targeting viral RNA sequences, making it a promising approach for antiviral strategies. Understanding the influence of template RNA structure on Cas13d binding and cleavage efficiency is crucial for optimizing its therapeutic potential. In this study, we investigated the effect of local RNA secondary structure on Cas13d activity. To do so, we varied the stability of a hairpin structure containing the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) target sequence, allowing us to determine the threshold RNA stability at which Cas13d activity is affected. Our results demonstrate that Cas13d possesses the ability to effectively bind and cleave highly stable RNA structures. Notably, we only observed a decrease in Cas13d activity in the case of exceptionally stable RNA hairpins with completely base-paired stems, which are rarely encountered in natural RNA molecules. A comparison of Cas13d and RNA interference (RNAi)-mediated cleavage of the same RNA targets demonstrated that RNAi is more sensitive for local target RNA structures than Cas13d. These results underscore the suitability of the CRISPR-Cas13d system for targeting viruses with highly structured RNA genomes.

Identifiants

pubmed: 39220269
doi: 10.1016/j.omtn.2024.102278
pii: S2162-2531(24)00165-3
pmc: PMC11364014
doi:

Types de publication

Journal Article

Langues

eng

Pagination

102278

Informations de copyright

© 2024 The Author(s).

Déclaration de conflit d'intérêts

The authors declare no competing interests.

Auteurs

Mouraya Hussein (M)

Amsterdam UMC, University of Amsterdam, Medical Microbiology and Infection Prevention, Meibergdreef 9, Amsterdam, the Netherlands.
Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam, the Netherlands.

Ye Liu (Y)

Amsterdam UMC, University of Amsterdam, Medical Microbiology and Infection Prevention, Meibergdreef 9, Amsterdam, the Netherlands.
Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam, the Netherlands.

Monique Vink (M)

Amsterdam UMC, University of Amsterdam, Medical Microbiology and Infection Prevention, Meibergdreef 9, Amsterdam, the Netherlands.
Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam, the Netherlands.

Pascal Z Kroon (PZ)

Amsterdam UMC, University of Amsterdam, Medical Microbiology and Infection Prevention, Meibergdreef 9, Amsterdam, the Netherlands.
Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam, the Netherlands.

Atze T Das (AT)

Amsterdam UMC, University of Amsterdam, Medical Microbiology and Infection Prevention, Meibergdreef 9, Amsterdam, the Netherlands.
Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam, the Netherlands.

Ben Berkhout (B)

Amsterdam UMC, University of Amsterdam, Medical Microbiology and Infection Prevention, Meibergdreef 9, Amsterdam, the Netherlands.
Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam, the Netherlands.

Elena Herrera-Carrillo (E)

Amsterdam UMC, University of Amsterdam, Medical Microbiology and Infection Prevention, Meibergdreef 9, Amsterdam, the Netherlands.
Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam, the Netherlands.

Classifications MeSH